Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

chimeric

chimeric is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 16
News articles 0
Drug details — chimeric
Class
—
Route
—
Patents
20
Programs
16
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

chimeric is an FDA-listed pharmaceutical active ingredient.

Key facts

INN chimeric

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. Live attenuated Japanese encephalitis chimeric virus vaccine Phase 3 · Sanofi Pasteur MSD · Japanese Encephalitis
  2. KYV101-003 Phase 2 · Kyverna Therapeutics · Lupus Nephritis
  3. autologous anti-BCMA chimeric antigen receptor T cells Phase 2 · First People's Hospital · ITP
  4. BCSW-LDP+CDP1-Ⅰ-01 Phase 1 · Chinese Academy of · Advanced Malignant Tumor
  5. CAR T cells chimeric antigenreceptor cells Phase 1 · Chinese Academy of · Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
  6. CAR-T cells Infusion chimeric antigen receptor T cells Phase 1 · First People's Hospital · Relapsed/Refractory Plasma Cell Leukemia
  7. CAR-T cells chimeric antigen receptor T cells Phase 1 · Chinese Academy of · Relapsed/Refractory Acute Myeloid Leukemia(AML)
  8. CD19/BCMA-Targeted Universal Chimeric Antigen Receptor T Cells (UCAR-T) infusing Phase 1 · First People's Hospital · Refractory Idiopathic Membranous Nephropathy

Related patents

Browse patents

  1. US 12428463

    Chimeric antigen receptors targeting abnormal glycobiology

    Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12421292

    Anti-DLL3 chimeric antigen receptors and uses thereof

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12415867

    Anti-DCLK1 antibodies and chimeric antigen receptors, and compositions and methods of use thereof

    Expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12410232

    Treatment of a canine CD20 positive disease or condition using a canine CD20-specific chimeric antigen receptor

    Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12404347

    Glucuronoxylomannan (GXM) receptor chimeric antigen receptors and use thereof

    Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12398194

    Cell lexpressing two chimeric antigen receptors (CARs) at the cell surface

    Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12370261

    Chimeric peptides for antisense delivery

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12371466

    Chimeric antigen receptor and methods of use thereof

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12365879

    Synthetic chimeric poxviruses

    Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 12358988

    Proteolytically cleavable chimeric polypeptides and methods of use thereof

    Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 12351614

    CLEC9A-based chimeric protein complexes

    Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 12351638

    Chimeric antigen receptors targeting BCMA and methods of use thereof

    Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 12338459

    DNA-chimeric antigen receptor T cells for immunotherapy

    Expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 12310988

    BCMA chimeric antigen receptors and uses thereof

    Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 12304942

    Cell comprising a chimeric antigen receptor or a transgenic T-cell receptor and comprising a chimeric TNF receptor

    Expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 12304968

    T-cells expressing anti-LIV1 chimeric antigen receptor

    Expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 12297259

    Aspergillus antigen chimeric receptors and use thereof

    Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 12291557

    Chimeric TIM4 receptors and uses thereof

    Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 12281164

    Genetically engineered dual-targeting chimeric antigen receptor and use thereof

    Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 12269860

    Compositions and methods comprising engineered chimeric antigen receptor and modulator of CAR

    Expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is chimeric?

chimeric is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.